Ocugen, Inc. (OCGN)
1.415
+0.06
(+4.04%)
USD |
NASDAQ |
Aug 25, 11:00
Ocugen Total Assets (Quarterly) : 124.21M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 124.21M |
| March 31, 2026 | 56.90M |
| December 31, 2025 | 44.29M |
| September 30, 2025 | 57.60M |
| June 30, 2025 | 53.59M |
| March 31, 2025 | 64.46M |
| December 31, 2024 | 83.34M |
| September 30, 2024 | 61.94M |
| June 30, 2024 | 40.54M |
| March 31, 2024 | 51.79M |
| December 31, 2023 | 65.46M |
| September 30, 2023 | 74.69M |
| June 30, 2023 | 88.98M |
| March 31, 2023 | 96.30M |
| December 31, 2022 | 109.61M |
| September 30, 2022 | 116.24M |
| June 30, 2022 | 130.09M |
| March 31, 2022 | 141.73M |
| December 31, 2021 | 105.76M |
| September 30, 2021 | 116.31M |
| June 30, 2021 | 124.25M |
| March 31, 2021 | 53.85M |
| December 31, 2020 | 27.38M |
| September 30, 2020 | 20.54M |
| June 30, 2020 | 23.76M |
| Date | Value |
|---|---|
| March 31, 2020 | 12.31M |
| December 31, 2019 | 16.81M |
| September 30, 2019 | 23.62M |
| June 30, 2019 | 3.20M |
| March 31, 2019 | 14.84M |
| December 31, 2018 | 2.454M |
| September 30, 2018 | 10.88M |
| June 30, 2018 | 15.15M |
| March 31, 2018 | 21.32M |
| December 31, 2017 | 11.04M |
| September 30, 2017 | 15.83M |
| June 30, 2017 | 22.13M |
| March 31, 2017 | 28.31M |
| December 31, 2016 | 36.08M |
| September 30, 2016 | 42.80M |
| June 30, 2016 | 21.28M |
| March 31, 2016 | 28.52M |
| December 31, 2015 | 36.79M |
| September 30, 2015 | 45.30M |
| June 30, 2015 | 53.24M |
| March 31, 2015 | 61.58M |
| December 31, 2014 | 65.50M |
| September 30, 2014 | 12.00M |
| June 30, 2014 | 14.84M |
| March 31, 2014 | 9.981M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 381.23M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Biogen, Inc. | 32.09B |
| Gilead Sciences, Inc. | 49.36B |
| MannKind Corp. | 732.30M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 140.76M |
| Shareholders Equity (Quarterly) | -16.56M |
| Debt to Equity Ratio | -5.314 |
| Current Ratio | 0.8019 |
| Net Debt Paydown Yield | -2.17% |